Table 1 Clinical characteristics of patients with metastatic pancreatic cancer and benign pancreatic cysts
From: Circulating CD8+CD122+ T cells as a prognostic indicator of pancreatic cancer
Characteristic | Metastatic pancreatic cancer | Benign pancreatic cyst | P-value |
|---|---|---|---|
Total number | 54 | 52 | Â |
Sex (%) | |||
 Male | 26 (48) | 25 (48) | 0.99 |
 Female | 28 (52) | 27 (52) |  |
Age (years) | |||
 Mean ± SD | 64.9 ± 8.9 | 65.2 ± 7.6 | 0.85 |
 Range | 42–79 | 44–76 |  |
Diabetes mellitus (%) | |||
 Yes | 23 (43%) | 12 (23%) | 0.038 |
Serum albumin (g/dL) | |||
 Median | 3.7 | 4.3 | <0.0001 |
 Range | 2.2–4.5 | 3.6–5.0 |  |
ECOG performance status (%) | |||
 0/1/2 | 31(57)/21(39)/2(4) |  |  |
1st line chemotherapy regimen (%) | |||
 S-IROX/mFFX/GnP | 2(3.7)/11(20.4)/41(75.9) |  |  |
T factor (%) | |||
 1/2/3/4 | 0/0/31(57)/23(43) |  |  |
Metastasis location (%) | |||
 Liver/Lung/Peritoneum/Bone | 32(59)/15(28)/17(31)/4(7) |  |  |
CA19-9 level (U/mL) | |||
 Median | 585.1 |  |  |
 Range | 1.5–606320 |  |  |